A Longitudinal Study to Explore the Impact of Gut Microbiome on Brain Health in Alzheimer's Disease

Recruiting Observational Study
Alzheimer Disease Gut Microbiota Metabonomics Magnetic Resonance Imaging
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
60 – 80
Sex
Any
Study type
Observational
Participants needed
285 (estimated)
Sponsor
Jining Medical University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Gut microbiota dysfunction is associated with Alzheimer's disease (AD). However, the potential modulatory mechanism remains unclear. Previous studies have shown that gut-derived metabolites short-chain fatty acids (SCFAs) may be the key mediators between gut microbiota and brain, participating in the modulatory pathway "gut microbiota-SCFAs-brain networks". In this project, high-throughput targete…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Cognitively normal group: 1. normal performance on standardized cognitive tests; 2. with no cognitive complaints or any concerns (worries). * SCD group: 1. self-experienced persistent decline in memory, rather than other domains of cognition; 2. normal performance on…
Contacts

Can Sheng, PhD

86-18701257298

canyeweiwu2013@163.com

CONTACT

Yun Guo, Master

86-18863030588

yun125985@163.com

CONTACT